Matthew Akiyama, MD, MSc
Assistant Professor of Medicine
Department of Medicine: Divisions of General
Internal Medicine & Infectious Diseases
Montefiore Medical Center
Albert Einstein College of Medicine
Bronx, New York

Mandy Altman, MPA, CCHP
Director, Correctional Health Program
Hepatitis Education Project
National Hepatitis Corrections Network
Seattle, Washington

Lara Strick, MD, MSc
Clinical Associate Professor
University of Washington
Infectious Disease Physician
Washington State Department of Corrections
Tumwater, Washington

Tracy Swan
HIV and Hepatitis C Educator, Advocate,
and Policy Advisor
Brooklyn, NY

Alysse G. Wurcel, MD, MS
Assistant Professor, Tufts Medical Center
Department of Medicine: Division of Geographic
Medicine and Infectious Diseases
Tufts University School of Medicine
Department of Public Health and
Community Medicine
Boston, Massachusetts

Program Description

We, in the correctional community, have a critical part to play in shaping health care delivery and advocating for our patients. This is especially pertinent to HCV care, in which significant gaps in testing, treatment, prevention, and education persist—both behind bars and upon community reentry. Across the corrections-based HCV-care continuum, providers are faced not only with challenges, but also with opportunities and options. This CorrectCare InPractice/InContext™ HCV supplement is intended to provide highly relevant educational content, best-practice principles, and real-world perspectives for corrections-based HCV-care delivery and advocacy.

Target Audience

This activity has been designed to meet the educational needs of correctional health care professionals who treat incarcerated persons with or at risk for hepatitis C virus (HCV).

Educational Objectives

Upon completion of this activity, participants will be better able to:

  • Describe epidemiologic trends in HCV within correctional institutions
  • Provide opt-out HCV testing in accordance with current guideline recommendations
  • Demonstrate knowledge of corrections-based HCV treatment and prevention
  • Identify challenges to effective HCV treatment and prevention within the correctional setting and at the time of community reentry

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers, and other individuals and their spouses/life partners who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. The faculty reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity:

Matthew Akiyama, MD, MSc: No financial relationship to disclose
Mandy Altman, MPA: No financial relationship to disclose
Lara Strick, MD, MSc: No financial relationship to disclose
Tracy Swan: No financial relationship to disclose
Alyssa G. Wurcel, MD, MS: No financial relationship to disclose

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity:

Lindsay Borvansky: Nothing to disclose
Ashley Cann: Nothing to disclose
Andrea Funk: Nothing to disclose
Liddy Knight: Nothing to disclose
Jim Kappler, PhD: Nothing to disclose
Ashley Marostica, RN, MSN: Nothing to disclose
Jeanette Ruby, MD: Nothing to disclose

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas Communications. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This educational activity for 1.0 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Fee Information

There is no fee for this educational activity.

Global Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Global Education Group (Global) and Integritas Communications do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Begin Activity